Detalles de la búsqueda
1.
Gemtuzumab ozogamicin plus midostaurin in combination with standard '7 + 3' induction therapy in newly diagnosed AML: Results from the SAL-MODULE phase I study.
Br J Haematol;
204(6): 2254-2258, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593353
2.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica;
2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38654660
3.
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience.
Br J Cancer;
129(7): 1126-1133, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37542108
4.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Haematologica;
108(1): 34-41, 2023 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35678031
5.
Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
Blood;
136(7): 823-830, 2020 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496541
6.
Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial.
Lancet Oncol;
19(12): 1668-1679, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30442503
7.
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.
Leuk Lymphoma;
: 1-11, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38712673
8.
Proteomic profiling reveals ACSS2 facilitating metabolic support in acute myeloid leukemia.
Cancer Gene Ther;
2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38851813
9.
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.
Leukemia;
38(6): 1213-1222, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744920
10.
Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML).
Leukemia;
37(1): 134-142, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36411356
11.
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry.
J Cancer Res Clin Oncol;
149(8): 4611-4621, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36167894
12.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Lancet Haematol;
10(7): e495-e509, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37187198
13.
Midostaurin plus intensive chemotherapy for younger and older patients with AML and FLT3 internal tandem duplications.
Blood Adv;
6(18): 5345-5355, 2022 09 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35486475
14.
Adoptive Cell Transfer of Allogeneic Epstein-Barr Virus-Specific T Lymphocytes for Treatment of Refractory EBV-Associated Posttransplant Smooth Muscle Tumors: A Case Report.
Front Immunol;
12: 727814, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34925312
15.
Rationale and design of the 2 by 2 factorial design GnG-trial: a randomized phase-III study to compare two schedules of gemtuzumab ozogamicin as adjunct to intensive induction therapy and to compare double-blinded intensive postremission therapy with or without glasdegib in older patients with newly diagnosed AML.
Trials;
22(1): 765, 2021 Nov 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34732236
16.
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
Blood Cancer J;
11(10): 164, 2021 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34608129
17.
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia - implications for the European LeukemiaNet risk classification.
Leukemia;
37(11): 2282-2285, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37679502
18.
Safety and feasibility of stem cell boost as a salvage therapy for severe hematotoxicity after CD19 CAR T-cell therapy.
Blood Adv;
6(16): 4719-4725, 2022 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35793454
19.
A Rare Case of Acute Myeloid Leukemia with a t(2;3) Chromosomal Translocation Characterized by Thrombophilia and Chemoresistance.
J Clin Exp Hematop;
56(1): 64-8, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27334861
20.
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia.
Mol Cell Ther;
3: 2, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056603